JUST over a year after agritech and medtech incubator Trendlines Group aborted plans to list on the resource-centric Canadian stock exchange, the Israeli firm will soon claim a seat on Singapore's Catalist.
Trendlines' S$25 million initial public offering - its debut is slated for this Thursday - will make it the first Israeli firm to be listed on SGX in over a decade since Sarine Technologies.
"Investors in Singapore have asked the same hard questions we were asked in Canada. But they understand the answers in a different way ," says Steve Rhodes, co-founder of the firm that specialises in startups in medical devices and agricultural technology.
"And that's what it really comes down to...